Literature DB >> 3021868

Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex.

C V Sumaya, R N Boswell, Y Ench, D L Kisner, E M Hersh, J M Reuben, P W Mansell.   

Abstract

The potential involvement of Epstein-Barr virus (EBV) in AIDS was examined by determining the type of EBV-specific antibody responses and the EBV content or lymphoproliferative ability present in selected body fluids of patients with AIDS or AIDS-related complex. The results were compared with two control groups. An enhanced antibody response to a broad spectrum of EBV antigens was found in patients with AIDS or AIDS-related complex. The pattern of virus-specific antibody responses resembled that associated with a persistent or reactivated infection. The content of EBV in oropharyngeal secretions and the lymphoproliferative ability in peripheral blood from patients with AIDS or AIDS-related complex was significantly greater than that from healthy controls and approached levels detected in the control group with infectious mononucleosis. These findings, together with recent reports of cellular-level interaction between EBV and human T lymphotropic virus type III, suggest that EBV may have a contributory role in these disorders.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021868     DOI: 10.1093/infdis/154.5.864

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Authors:  S Morgello
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 2.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Immunoglobulin G, A, and M responses to BK virus in renal transplantation.

Authors:  Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Journal:  Clin Vaccine Immunol       Date:  2006-09

4.  Epstein-Barr virus infection in 59 orthotopic liver transplant patients.

Authors:  M E Lamy; A M Favart; C Cornu; M Salizzoni; N Cimadamore; B de Hemptinne; J B Otte
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.

Authors:  B Winkelspecht; F Grässer; H W Pees; N Mueller-Lantzsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1.

Authors:  K E Dahl; T Burrage; F Jones; G Miller
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients.

Authors:  R Tedeschi; J Dillner; P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

8.  Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus.

Authors:  M A Rahman; L A Kingsley; R W Atchison; S Belle; M C Breinig; M Ho; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

9.  Evidence of an in vitro association between human immunodeficiency virus antigen P24 and Epstein-Barr virus DNA.

Authors:  P Lardelli; S M Steinberg; C Campelo; A F de Aranguiz; L Sarría; M T Gorriño; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

10.  Association between HIV and other DNA viruses in vitro.

Authors:  R Cisterna; C Campelo; T Gorriño; C Malavé; L Sarría; P Lardelli; A Fernandez de Aranguiz; L Madariaga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.